FOLH1 and pachyonychia congenita: Their results indicated that 177Lu-labeled anti-PSMA 3F11 showed high specificity and affinity for a xenograft mouse model, making it a potential candidate for radioimmunotherapeutic applications in PC.90 However, the literature on the use of this system for miRNA delivery in PC treatment is rare.